Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
/C O R R E C T I O N -- Korean Ginseng Research Institute/ 2021-10-22 17:20
/C O R R E C T I O N -- Korean Ginseng Research Institute/ 2021-10-22 16:28
Educating children about good hygiene is key to helping reduce future health threats 2021-10-22 14:01
Aero HygenX Partners with Ethiopian Airlines for Deployment of Autonomous UV-C Disinfecting Solution 2021-10-21 21:57
INOVIO Announces Collaboration with Colombia; Memorandum of Understanding Focuses on Protecting Against COVID-19 and Supporting Broader Health Preparedness Initiatives 2021-10-21 20:00
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine 2021-10-20 21:24
Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference 2021-10-20 20:52
Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources 2021-10-20 13:29
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections 2021-10-19 09:00
Novavax to Participate in World Vaccine Congress Europe 2021-10-16 04:39
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine 2021-10-15 18:36
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effective Universal Booster For Vaccines Produced By AstraZeneca, Sinopharm, Moderna And Cansino Inducing Strong Immune Response And Showing High Safety Profile. Combination Of AstraZeneca And Sputnik Light Vaccines Showed High Immunogenicity Results. 2021-10-15 05:26
More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals 2021-10-13 05:00
Brii Bio Initiates Submission of Emergency Use Authorization Filing to U.S. FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk of Clinical Progression to Severe Disease 2021-10-09 03:07
RedHill Biopharma Reports Further Analysis of Phase 2/3 Data Including a 62% Reduction in Mortality with Oral Opaganib in Moderately Severe COVID-19 Patients 2021-10-04 21:24
Brii Bio Presents Positive Phase 3 Data on BRII-196/BRII-198, the Company's SARS-CoV-2 Monoclonal Neutralizing Antibody Combination Therapy, in an Oral Late-Breaker Presentation at IDWeek 2021 2021-10-04 08:00
Impact Credit Solutions and Bank Central Asia partner to offer financing to the Indonesian healthcare sector 2021-09-30 09:00
Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India 2021-09-28 14:57
Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy 2021-09-28 08:00
LEAD Horizon: How travelers in Austria gargle against the corona virus 2021-09-27 09:00
1 23 24 25 26 27 91